Lenalidomid Sandoz 5 mg tvrde kapsule
| Name | Lenalidomid Sandoz 5 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-394924085 |
| Active Substance | lenalidomid |
| Composition | svaka kapsula sadrži 5 mg lenalidomida |
| Pharmaceutical Form | kapsula, tvrda |
| Packaging [MA Number for Packaging] | 7 kapsula u blisteru, u kutiji [HR-H-394924085-01] 14 kapsula u blisteru, u kutiji [HR-H-394924085-02] 21 kapsula u blisteru, u kutiji [HR-H-394924085-03] 28 kapsula u blisteru, u kutiji [HR-H-394924085-04] 42 kapsule u blisteru, u kutiji [HR-H-394924085-05] 7 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-394924085-06] 14 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-394924085-07] 21 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-394924085-08] 28 kapsula u blisteru s jediničnom dozom, u kutiji [HR-H-394924085-09] |
| Manufacturer | Synthon Hispania S.L., Barcelona, Španjolska Synthon BV, Nijmegen, Nizozemska Salutas Pharma GmbH, Barleben, Njemačka |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 21.04.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/186 |
| Registration Number | 381-12-01/171-23-05 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L04AX04 |
| Medicinal product marketed in the Croatia | Trajni prekid opskrbe |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
